Roivant Sciences Ltd (NASDAQ: ROIV) is -1.46% lower on its value in year-to-date trading and has touched a low of $8.73 and a high of $13.06 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ROIV stock was last observed hovering at around $11.65 in the last trading session, with the day’s loss setting it -0.21%.
Currently trading at $11.44, the stock is 1.05% and 2.56% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.93 million and changing -1.80% at the moment leaves the stock 2.36% off its SMA200. ROIV registered -3.30% loss for a year compared to 6-month gain of 3.34%. The firm has a 50-day simple moving average (SMA 50) of $11.1541 and a 200-day simple moving average (SMA200) of $11.176525.
The stock witnessed a 2.97% loss in the last 1 month and extending the period to 3 months gives it a 14.17%, and is 0.70% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.74% over the week and 2.82% over the month.
Roivant Sciences Ltd (ROIV) has around 750 employees, a market worth around $7.78B and $76.19M in sales. Profit margin for the company is -225.71%. Distance from 52-week low is 31.04% and -12.37% from its 52-week high. The company has generated returns on investments over the last 12 months (-3.60%).
with sales reaching $7.16M over the same period.The EPS is expected to shrink by -393.55% this year, but quarterly earnings will post 0.63% year-over-year. Quarterly sales are estimated to shrink -87.02% in year-over-year returns.
Roivant Sciences Ltd (ROIV) Top Institutional Holders
408.0 institutions hold shares in Roivant Sciences Ltd (ROIV), with institutional investors hold 119.83% of the company’s shares. The shares outstanding are 695.94M, and float is at 401.31M with Short Float at 10.24%. Institutions hold 83.52% of the Float.
The top institutional shareholder in the company is SB INVESTMENT ADVISERS (UK) LTD with over 71.36 million shares valued at $754.29 million. The investor’s holdings represent 9.6983% of the ROIV Shares outstanding. As of 2024-06-30, the second largest holder is VIKING GLOBAL INVESTORS LP with 69.16 million shares valued at $730.98 million to account for 9.3985 of the shares outstanding. The other top investors are QVT FINANCIAL LP which holds 66.72 million shares representing 9.0674% and valued at over $705.23 million, while FMR LLC holds 6.3265 of the shares totaling 46.55 million with a market value of $492.05 million.
Roivant Sciences Ltd (ROIV) Insider Activity
The most recent transaction is an insider sale by Venker Eric, the company’s President & COO. SEC filings show that Venker Eric sold 100,000 shares of the company’s common stock on Jun 20 ’25 at a price of $11.45 per share for a total of $1.15 million. Following the sale, the insider now owns 1.46 million shares.
Roivant Sciences Ltd disclosed in a document filed with the SEC on Jun 20 ’25 that Ramaswamy Vivek (10% Owner) sold a total of 577,007 shares of the company’s common stock. The trade occurred on Jun 20 ’25 and was made at $11.46 per share for $6.61 million. Following the transaction, the insider now directly holds 37.28 million shares of the ROIV stock.
Still, SEC filings show that on Jun 18 ’25, Ramaswamy Vivek (10% Owner) disposed off 565,266 shares at an average price of $11.45 for $6.47 million. The insider now directly holds 37,861,115 shares of Roivant Sciences Ltd (ROIV).
